# Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

*PRI Rank #20 · Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026/rank-20*

| Field | Value |
| --- | --- |
| Rank | #20 |
| 18m citations | 36 |
| Journal | The Lancet Haematology |
| Year | 2024 |
| DOI | 10.1016/s2352-3026(24)00065-6 |
| Corresponding authors | Johannes Schetelig, Johannes Schetelig |
| Institution | University Hospital Münster, Germany |

**Ranking page:** [Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026](https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026)

**Paper link:** [10.1016/s2352-3026(24)00065-6](https://doi.org/10.1016/s2352-3026(24)00065-6)

## Topics

Acute myeloid leukemia (AML) · allogeneic haematopoietic stem cell transplantation · high-dose cytarabine · salvage chemotherapy · mitoxantrone · Induction chemotherapy · watchful waiting · disease control · non-inferiority trial · Complete remission (CR) · Relapsed AML · poor responsive acute myeloid leukaemia · intensive conditioning · Treatment response · non-favourable-risk acute myeloid leukaemia · treatment-related complications · progressive acute myeloid leukaemia · intention-to-transplant

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```